ConductScience.org, home

Trial · NCT01515774

Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID)

NCT01515774, Phase 4, Unknown, Seoul National University Hospital

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID). Trials, record NCT01515774. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01515774

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID)
NCT number
NCT01515774
Status
Unknown
Phases
Phase 4
Enrollment
200 participants, estimated
Lead sponsor
Seoul National University Hospital
Conditions
Parkinson's Disease
Interventions
Mirapex ER
First posted
2012-01-24
Last updated
2012-01-24

Source ClinicalTrials.gov

Registered outcomes8

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPatient preference4 monthsOverall preference in QD versus BID
SecondaryMotor complications2 months at each armVisual rating scale for off severity, dyskinesia severity Duration - off duration, dyskinesia duration
SecondarySleep problems2 months at each armParkinson's disease sleep scale (PDSS) Excessive daytime sleepiness scale(ESS)
SecondaryMotor UPDRS and HY stage2months at each arm
SecondarySide effects2 months at each armRating scale (0\~10): Nausea, Dizziness, Somnolence, Headache, Constipation, Dyspepsia, Fatigue, Hallucination, Edema, Dry mouth,Others
SecondaryPatient global impression for improvement2 months at each arm
SecondaryPreference in each factor4 monthsPreference of QD versus BID in each factor: off duration, off severity, dyskinesia duration, dyskinesia severity, on quality, adverse events, sleep quality, convenience
SecondaryPatient choice4 monthsPatient choice in QD or BID Reason for the choice

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers3

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
20110012BACKGROUNDPubMed
20669265BACKGROUNDPubMed
28265478DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01515774

GET https://conductscience.org/api/trials/v1/NCT01515774/registered